Strategic Intelligence: Medical Devices M&A Deals H1 2026 - Top Themes
Summary
This report analyzes the disruptive themes that have driven M&A activity in H1 2026 in the Medical Devices Sector
Key Highlights
- The global medical devices market witnessed deals worth $67 billion in H1 2026, an increase of 150% compared to H1 2025. The sector recorded deal value worth $48 billion mega-deals (defined as any deal valued at more than $1 billion), an increase of 175% compared to H1 2025.
Scope
- This report provides an overview of merger and acquisition activity globally in H1 2026 in Medical Devices Sector
- It identifies the themes driving most notable to deals announced in H1 2026 in the Medical Devices Sector
Reasons to Buy
- Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
- In this report we have listed down the most notable deals in medical devices sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Table of Contents
- Executive Summary
- Review of the Medical Devices M&A Market - H1 2026
- Medical Devices M&A Deals Analysis by Geography - H1 2026
- Further Reading
- Report Authors
- Appendix 1: Deal Selection Criteria
- Appendix 2: Our Thematic Research Methodology
- Contact Us
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific Corp
- Merck KGaA
- Danaher Corp
- Amplifon SpA
- Jardine Matheson Holdings Ltd
- Boston Scientific Corp
- American Industrial Partners
- Apollo Funds
- Astorg Partners
- Roche Holding AG
- Penumbra Inc
- Bio-Techne Corp
- Masimo Corp
- GN Store Nord
- I-MED Radiology Network Ltd
- MiRus LLC
- Avanos Medical Inc
- McKesson Medical-Surgical Solutions
- Thermo Fisher Scientific
- PathAI Inc

